What is the recommended treatment for tetanus, including wound care, passive and active immunization, antibiotics, and spasm control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Tetanus

Tetanus treatment requires immediate wound debridement, passive immunization with tetanus immune globulin (TIG) 250 units IM, active immunization with tetanus toxoid, antibiotics (metronidazole or penicillin), and aggressive spasm control with benzodiazepines, with early consideration for mechanical ventilation in severe cases.

Wound Management

Proper wound care and debridement are critical first steps in tetanus management 1. The wound must be thoroughly debrided to remove devitalized tissue and create an aerobic environment that prevents further toxin production by Clostridium tetani spores 2. This is foundational because the organism proliferates only under anaerobic conditions.

Passive Immunization

Administer TIG 250 units intramuscularly immediately for both adults and children 1. This neutralizes circulating unbound toxin before it binds to neuronal cell membranes 3. Key points:

  • Use separate syringes and injection sites if administering TIG concurrently with tetanus toxoid 1
  • If TIG is unavailable, intravenous immune globulin (IVIG) may be substituted 1
  • TIG only neutralizes circulating toxin; it cannot reverse toxin already bound to neurons 2

Active Immunization

Initiate active immunization with tetanus toxoid immediately, as tetanus infection does not confer natural immunity 1:

  • Adults: Td or Tdap (Td preferred for those >65 years) 1
  • Children: Age-appropriate vaccine (DTaP if <7 years, Td if 7-10 years, Tdap if ≥11 years) 1
  • Ensure completion of the 3-dose primary series for those with uncertain or incomplete vaccination history 1

Antibiotic Therapy

Metronidazole is the preferred antibiotic; penicillin G is an alternative 4, 5. Antibiotics eradicate locally proliferating bacteria at the wound site and reduce further toxin production 6, 3. Note that postexposure antimicrobial chemoprophylaxis alone (without wound care and immunization) is not recommended 1.

Spasm Control

This is the most challenging aspect of tetanus management and directly impacts mortality:

First-line: Benzodiazepines

  • Diazepam is the mainstay, administered in large doses (0.2-1 mg/kg/hour) via nasogastric tube 4
  • Benzodiazepines reduce rigidity, spasms, and autonomic dysfunction 4

Adjunctive Therapy: Magnesium Sulfate

  • Intravenous magnesium sulfate infusion helps control spasms and manage autonomic overactivity 2, 4
  • Recent research supports its use to potentially avoid mechanical ventilation 2

Refractory Cases

  • Neuromuscular blocking agents with mechanical ventilation are required when spasms remain uncontrolled 4
  • Early elective tracheostomy should be performed in moderate-to-severe tetanus to prevent aspiration and manage laryngeal stridor 4
  • Intrathecal baclofen (either continuous infusion or intermittent boluses) is highly effective for refractory spasms, though resource-intensive 7

Supportive Care

  • Nasogastric tube placement for feeding and medication administration 4
  • Low-stimulation environment (minimize touch, noise, bright lights that trigger spasms) 4, 5
  • Manage autonomic dysfunction (labile hypertension, tachycardia, excessive secretions) - this is difficult and a common cause of mortality 4
  • Monitor for and prevent secondary complications including hospital-acquired infections, rhabdomyolysis from severe spasms, and aspiration 2

Critical Pitfalls

The case-fatality ratio for tetanus remains 18% in the United States and ranges from 5-50% globally 1, 4. Without access to mechanical ventilation, mortality remains high 2. Patients require several weeks of hospitalization even with optimal care 2. Autonomic instability (dysautonomia) is particularly difficult to manage and represents a major cause of death 4.

High-risk populations include adults >60 years (at least 40% lack protective antibody levels), immigrants from regions outside North America/Europe, and inadequately vaccinated individuals 1. When vaccination history is uncertain in the setting of tetanus-prone wounds, err on the side of providing both active and passive immunization 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.